A strong enrichment in interferon (IFN) response signalling in fibroblasts in CC with CTX‐treated cancer cells was observed (Fig. 3C and Fig. S5B; Fig. 5A and Fig. S7A for paclitaxel and epirubicin, respectively. This evidence concerns the gene IFNA1 and cancer.